Dyne Therapeutics annual debt-to-assets ratio
2020
2021
2022
2023
2024
2025
Dyne Therapeutics Debt-to-Assets Ratio Growth & History (DYN)
Dyne Therapeutics's debt-to-assets ratio was 0.14 for fiscal 2025.
View full Dyne Therapeutics company overviewDyne Therapeutics annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.14 | 0.11 | +310.77% |
| 2024 | 2024-12-31 | 0.03 | −0.13 | −79.10% |
| 2023 | 2023-12-31 | 0.17 | 0.07 | +66.88% |
| 2022 | 2022-12-31 | 0.10 | 0.02 | +29.79% |
| 2021 | 2021-12-31 | 0.08 | 0.08 | — |
| 2020 | 2020-12-31 | 0.00 | — | — |
Dyne Therapeutics quarterly debt-to-assets ratio
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.22 | 0.05 | +32.77% |
| Q1 2026 | 2026-03-31 | 0.16 | 0.12 | +382.75% |
| Q4 2025 | 2025-12-31 | 0.14 | 0.11 | +310.77% |
| Q3 2025 | 2025-09-30 | 0.14 | 0.11 | +329.72% |
| Q2 2025 | 2025-06-30 | 0.17 | 0.13 | +433.38% |
| Q1 2025 | 2025-03-31 | 0.03 | −0.02 | −36.51% |
| Q4 2024 | 2024-12-31 | 0.03 | −0.13 | −79.10% |
| Q3 2024 | 2024-09-30 | 0.03 | −0.11 | −76.49% |
| Q2 2024 | 2024-06-30 | 0.03 | −0.08 | −73.04% |
| Q1 2024 | 2024-03-31 | 0.05 | −0.05 | −50.58% |
| Q4 2023 | 2023-12-31 | 0.17 | 0.07 | +66.88% |
| Q3 2023 | 2023-09-30 | 0.14 | 0.03 | +32.14% |
| Q2 2023 | 2023-06-30 | 0.12 | 0.02 | +19.60% |
| Q1 2023 | 2023-03-31 | 0.10 | 0.02 | +21.99% |
| Q4 2022 | 2022-12-31 | 0.10 | 0.02 | +29.79% |
| Q3 2022 | 2022-09-30 | 0.10 | 0.03 | +42.92% |
| Q2 2022 | 2022-06-30 | 0.10 | 0.10 | +11093.35% |
| Q1 2022 | 2022-03-31 | 0.08 | 0.08 | +6873.76% |
| Q4 2021 | 2021-12-31 | 0.08 | 0.08 | — |
| Q3 2021 | 2021-09-30 | 0.07 | 0.05 | +179.59% |
| Q2 2021 | 2021-06-30 | 0.00 | — | — |
| Q1 2021 | 2021-03-31 | 0.00 | — | — |
| Q4 2020 | 2020-12-31 | 0.00 | — | — |
| Q3 2020 | 2020-09-30 | 0.03 | — | — |
Dyne Therapeutics debt-to-assets ratio trends
Over the last five fiscal years, Dyne Therapeutics's debt-to-assets ratio increased from 0.00 to 0.14, a change of 0.14. The latest reported quarter, Q2 2026, shows 0.22.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dyne Therapeutics source filings ↗Community posts
Novartis’ DM1 trial misses its primary endpoint
Novartis’ ($NVS) del-desiran failed to show a statistically significant improvement on the primary endpoint in the Phase III HARBOR trial for myotonic dystrophy type 1. The company will continue analysing the data and discuss next steps wit ...